K

Kaiser Permanente | Division of Research

Research site
(Unclaimed)
Location
2000 Broadway, Oakland, California, United States of America
Site insights

Top conditions

Fibrosis (8 trials)

Cystic Fibrosis (7 trials)

Infections (2 trials)

Alopecia (2 trials)

Communicable Diseases (2 trials)

Top treatments

VX-121
VX-445
CTP-543
Icosapent Ethyl
pegcrisantaspase
BMS-986036
Aztreonam
Nucleos(t)Ide
Olaparib
Lenacapavir

Parent organization

This site is a part of Kaiser Permanente

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 23
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in pa...

Active, not recruiting
Cystic Fibrosis
Drug: VX-121/TEZ/D-IVA

Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy.

Active, not recruiting
FIGO Stage III-IV
Newly Diagnosed
Drug: Olaparib 300mg tablets

The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.

Active, not recruiting
Pre-Exposure Prophylaxis of HIV Infection
Drug: Oral Lenacapavir (LEN)
Drug: F/TDF

Trial sponsors

Kaiser Permanente logo

Kaiser Permanente (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems